Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase Iii Studies (Sign Trials)

AuthID
 P-00S-ZZV
15
Author(s)
Lambert, E
·
Penelaud, PF
·
Severo, CA
·
Fuentes, J
·
Rosier, A
·
Hervas, A
·
Marret, S
·
Oliveira, G
·
Parellada, M
·
Bertrand, M
·
Ravel, D
·
Tipo de Documento
Article in Press
Year published
2020
Publicado
in JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, ISSN: 0162-3257
Indexing
Wos®
Scopus®
Google Scholar®
Publication Identifiers
SCOPUS: 2-s2.0-85095451421
Wos: WOS:000586346100001
Source Identifiers
ISSN: 0162-3257
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service